DK1200419T3 - Aminothiazolderivater og disses anvendelse som ligander for CRF-receptorer - Google Patents

Aminothiazolderivater og disses anvendelse som ligander for CRF-receptorer

Info

Publication number: DK1200419T3
Authority: DK; Denmark
Prior art keywords: ligands; crf receptors; aminothiazole derivatives; aminothiazole; derivatives
Prior art date: 1999-07-15

Application number

DK00951647T

Other languages

Danish (da)

English (en)

Inventor

Evelyne Fontaine

Michel Geslin

Danielle Gully

Antoine Pradines

Pierre Roger

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-15

Filing date

2000-07-11

Publication date

2004-07-19

2000-07-11 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2004-07-19 Application granted granted Critical

2004-07-19 Publication of DK1200419T3 publication Critical patent/DK1200419T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)

DK00951647T 1999-07-15 2000-07-11 Aminothiazolderivater og disses anvendelse som ligander for CRF-receptorer DK1200419T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9909144A FR2796380B3 (fr)	1999-07-15	1999-07-15	Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2000/001995 WO2001005776A1 (fr)	1999-07-15	2000-07-11	Derives d'aminothiazole et leur utilisation comme ligands des recepteurs crf

Publications (1)

Publication Number	Publication Date
DK1200419T3 true DK1200419T3 (da)	2004-07-19

Family

ID=9548107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00951647T DK1200419T3 (da)	1999-07-15	2000-07-11	Aminothiazolderivater og disses anvendelse som ligander for CRF-receptorer

Country Status (36)

Country	Link
US (2)	US6586456B1 (no)
EP (1)	EP1200419B1 (no)
JP (1)	JP4949582B2 (no)
KR (1)	KR100707320B1 (no)
CN (1)	CN1167692C (no)
AR (1)	AR024747A1 (no)
AT (1)	ATE264315T1 (no)
AU (1)	AU772683B2 (no)
BR (1)	BR0012478B1 (no)
CA (1)	CA2378792C (no)
CO (1)	CO5200792A1 (no)
CZ (1)	CZ300937B6 (no)
DE (1)	DE60009911T2 (no)
DK (1)	DK1200419T3 (no)
EA (1)	EA005159B1 (no)
EE (1)	EE05004B1 (no)
ES (1)	ES2220504T3 (no)
FR (1)	FR2796380B3 (no)
HK (1)	HK1045692B (no)
HU (1)	HU229069B1 (no)
IL (2)	IL147282A0 (no)
IS (1)	IS2314B (no)
ME (1)	MEP26608A (no)
MX (1)	MXPA02000545A (no)
NO (1)	NO324352B1 (no)
NZ (1)	NZ516397A (no)
PL (1)	PL206515B1 (no)
PT (1)	PT1200419E (no)
RS (1)	RS50443B (no)
SI (1)	SI1200419T1 (no)
SK (1)	SK287069B6 (no)
TR (1)	TR200200125T2 (no)
TW (1)	TWI278453B (no)
UA (1)	UA73125C2 (no)
WO (1)	WO2001005776A1 (no)
ZA (1)	ZA200200221B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU9625501A (en) *	2000-09-21	2002-04-02	Bristol Myers Squibb Co	Substituted azole derivatives as inhibitors of corticotropin releasing factor
EP1423113A4 (en) *	2001-08-13	2007-04-18	Phenex Pharmaceuticals Ag	NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
AU2002334772A1 (en)	2001-10-12	2003-04-28	Duke University	Methods for image analysis of high-density synthetic dna microarrays
EP2527446A1 (en)	2004-06-03	2012-11-28	Athlomics Pty Ltd	Agents and methods for diagnosing stress
RU2007109073A (ru) *	2004-08-13	2008-09-20	Дженентек, Инк. (Us)	Ингибиторы для атф-зависимого фермента на основе тиазола
EP1834641A1 (en) *	2006-03-16	2007-09-19	Sanofi-Aventis	Use of CRF1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
HUP0900267A2 (en)	2009-04-30	2011-03-28	Sanofi Aventis	Process for preparing of thiazole amines and intermediates thereof
EP2841068B8 (en) *	2012-04-23	2019-03-06	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Crhr1 antagonists for use in the treatment of patients having crh overactivity
GB201210686D0 (en)	2012-06-15	2012-08-01	Holsboermaschmeyer Neurochemie Gmbh	V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
GB201310782D0 (en)	2013-06-17	2013-07-31	Max Planck Innovation Gmbh	Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
CA3155599A1 (en)	2014-01-21	2015-07-30	Neurocrine Biosciences, Inc.	Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia
MX2021006552A (es) *	2018-12-07	2021-07-07	Neurocrine Biosciences Inc	Antagonista del receptor del factor de liberacion de corticotropina 1 (crf1), formulaciones farmaceuticas y formas solidas del mismo para el tratamiento de hiperplasia suprarrenal congenita.
JP7532328B2 (ja) *	2018-12-07	2024-08-13	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	先天性副腎過形成を処置するためのｃｒｆ１受容体アンタゴニスト、その医薬製剤および固体形態
US20220409592A1 (en) *	2019-09-27	2022-12-29	Neurocrine Biosciences, Inc.	Crf receptor antagonists and methods of use
EP4164636A1 (en)	2020-06-10	2023-04-19	Neurocrine Biosciences, Inc.	Crf1 receptor antagonist for the treatment of congenital adrenal hyperplasia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2692893B1 (fr)	1992-06-24	1994-09-02	Sanofi Elf	Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2714059B1 (fr) *	1993-12-21	1996-03-08	Sanofi Elf	Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2735777B1 (fr) *	1995-06-21	1997-09-12	Sanofi Sa	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2754258B1 (fr) *	1996-10-08	1998-12-31	Sanofi Sa	Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant

1999
- 1999-07-15 FR FR9909144A patent/FR2796380B3/fr not_active Expired - Lifetime
2000
- 2000-07-11 SK SK38-2002A patent/SK287069B6/sk not_active IP Right Cessation
- 2000-07-11 HU HU0202387A patent/HU229069B1/hu not_active IP Right Cessation
- 2000-07-11 US US10/031,038 patent/US6586456B1/en not_active Expired - Lifetime
- 2000-07-11 BR BRPI0012478-8B1A patent/BR0012478B1/pt not_active IP Right Cessation
- 2000-07-11 ES ES00951647T patent/ES2220504T3/es not_active Expired - Lifetime
- 2000-07-11 PT PT00951647T patent/PT1200419E/pt unknown
- 2000-07-11 AU AU64521/00A patent/AU772683B2/en not_active Ceased
- 2000-07-11 SI SI200030377T patent/SI1200419T1/xx unknown
- 2000-07-11 MX MXPA02000545A patent/MXPA02000545A/es active IP Right Grant
- 2000-07-11 CN CNB008116911A patent/CN1167692C/zh not_active Expired - Fee Related
- 2000-07-11 NZ NZ516397A patent/NZ516397A/xx not_active IP Right Cessation
- 2000-07-11 DK DK00951647T patent/DK1200419T3/da active
- 2000-07-11 TR TR2002/00125T patent/TR200200125T2/xx unknown
- 2000-07-11 AT AT00951647T patent/ATE264315T1/de active
- 2000-07-11 RS YUP-13/02A patent/RS50443B/sr unknown
- 2000-07-11 ME MEP-266/08A patent/MEP26608A/xx unknown
- 2000-07-11 KR KR1020027000549A patent/KR100707320B1/ko not_active IP Right Cessation
- 2000-07-11 JP JP2001511437A patent/JP4949582B2/ja not_active Expired - Lifetime
- 2000-07-11 IL IL14728200A patent/IL147282A0/xx active IP Right Grant
- 2000-07-11 EA EA200101234A patent/EA005159B1/ru not_active IP Right Cessation
- 2000-07-11 DE DE60009911T patent/DE60009911T2/de not_active Expired - Lifetime
- 2000-07-11 PL PL352901A patent/PL206515B1/pl unknown
- 2000-07-11 CA CA002378792A patent/CA2378792C/en not_active Expired - Fee Related
- 2000-07-11 EE EEP200200022A patent/EE05004B1/xx not_active IP Right Cessation
- 2000-07-11 WO PCT/FR2000/001995 patent/WO2001005776A1/fr active IP Right Grant
- 2000-07-11 EP EP00951647A patent/EP1200419B1/fr not_active Expired - Lifetime
- 2000-07-11 CZ CZ20020137A patent/CZ300937B6/cs not_active IP Right Cessation
- 2000-07-13 CO CO00052852A patent/CO5200792A1/es active IP Right Grant
- 2000-07-14 AR ARP000103626A patent/AR024747A1/es not_active Application Discontinuation
- 2000-07-14 TW TW089114114A patent/TWI278453B/zh not_active IP Right Cessation
- 2000-11-07 UA UA2001129084A patent/UA73125C2/uk unknown
2001
- 2001-12-24 IL IL147282A patent/IL147282A/en not_active IP Right Cessation
2002
- 2002-01-03 IS IS6219A patent/IS2314B/is unknown
- 2002-01-10 ZA ZA200200221A patent/ZA200200221B/en unknown
- 2002-01-11 NO NO20020155A patent/NO324352B1/no not_active IP Right Cessation
- 2002-10-04 HK HK02107310.6A patent/HK1045692B/zh not_active IP Right Cessation
2007
- 2007-04-25 US US11/740,001 patent/US8420679B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NZ516397A (en)	2004-01-30
SK287069B6 (sk)	2009-11-05
CO5200792A1 (es)	2002-09-27
SI1200419T1 (en)	2004-08-31
US6586456B1 (en)	2003-07-01
AU6452100A (en)	2001-02-05
JP4949582B2 (ja)	2012-06-13
RS50443B (sr)	2010-03-02
ZA200200221B (en)	2003-04-30
IL147282A0 (en)	2002-08-14
UA73125C2 (uk)	2005-06-15
EE200200022A (et)	2003-04-15
EE05004B1 (et)	2008-04-15
BR0012478B1 (pt)	2013-10-15
PL352901A1 (en)	2003-09-22
DE60009911T2 (de)	2005-03-10
TWI278453B (en)	2007-04-11
CN1167692C (zh)	2004-09-22
ES2220504T3 (es)	2004-12-16
KR20020015373A (ko)	2002-02-27
IS6219A (is)	2002-01-03
NO324352B1 (no)	2007-09-24
EP1200419A1 (fr)	2002-05-02
CN1370154A (zh)	2002-09-18
HK1045692A1 (en)	2002-12-06
MEP26608A (en)	2010-06-10
NO20020155D0 (no)	2002-01-11
HUP0202387A3 (en)	2004-12-28
DE60009911D1 (de)	2004-05-19
FR2796380A1 (fr)	2001-01-19
EA005159B1 (ru)	2004-12-30
SK382002A3 (en)	2002-07-02
EA200101234A1 (ru)	2002-08-29
ATE264315T1 (de)	2004-04-15
HU229069B1 (en)	2013-07-29
MXPA02000545A (es)	2002-07-30
US20070281919A1 (en)	2007-12-06
PT1200419E (pt)	2004-07-30
WO2001005776A1 (fr)	2001-01-25
BR0012478A (pt)	2002-04-02
FR2796380B3 (fr)	2001-08-17
NO20020155L (no)	2002-03-15
CZ300937B6 (cs)	2009-09-16
CZ2002137A3 (cs)	2002-04-17
US8420679B2 (en)	2013-04-16
TR200200125T2 (tr)	2002-09-23
YU1302A (sh)	2005-03-15
PL206515B1 (pl)	2010-08-31
HUP0202387A2 (hu)	2002-11-28
EP1200419B1 (fr)	2004-04-14
KR100707320B1 (ko)	2007-04-13
IS2314B (is)	2007-11-15
HK1045692B (zh)	2004-11-26
CA2378792C (en)	2009-11-10
AU772683B2 (en)	2004-05-06
AR024747A1 (es)	2002-10-23
IL147282A (en)	2008-04-13
JP2003505380A (ja)	2003-02-12
CA2378792A1 (en)	2001-01-25

Publication	Publication Date	Title
NO20000885L (no)	2000-08-25	4-Fenyl-pyridin-derivater
NO20021077D0 (no)	2002-03-05	Amino-triazolopyridin-derivater
DE60009747D1 (de)	2004-05-13	Admantan-derivate
ATE293104T1 (de)	2005-04-15	Thiazolylamid-derivate
IS6128A (is)	2001-10-26	13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
DK1200419T3 (da)	2004-07-19	Aminothiazolderivater og disses anvendelse som ligander for CRF-receptorer
PT1237857E (pt)	2004-10-29	Novos derivados fenalquiloxi-fenilo
ITMI992173A0 (it)	1999-10-18	Derivati isossazalcarbossamidici
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
ATE254598T1 (de)	2003-12-15	4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
DK1228041T3 (da)	2004-01-19	Indolderivater og anvendelse deraf som SHT2A-ligander
DE60025348D1 (de)	2006-03-30	Ethansulfonyl-piperidin-derivate
NO20020212D0 (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate
ITMI991704A0 (it)	1999-07-30	Derivati tienopirancarbossamidici
ATE217621T1 (de)	2002-06-15	Thiazol-derivate